← All verdicts
Verdict

Deep Overvalued

Every analyzed stock in Deep Overvalued1,218 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Deep Overvalued" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 3.1% below its 1-year high (as of 2026-09-16). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 7.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Proxy: price-to-book ≤ 1.2 (undervalued band has no point-in-time history yet) · bought the day of the annual report, held 12 months
Probable Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +12.6 pts (1,427 entries, 311 companies, very unlikely to be luck). 50% of entries beat the S&P; 25% beat it by 30 points or more; 30% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +10.9 pts.
+12.6 ptsvs S&P, average
50%beat the S&P
25%up 30+ pts vs S&P
30%down 20+ pts vs S&P
+14.0 ptsvs small caps, 12 mo
−15.1 pts 2019worst year to buy ?
6.1luck check ?
Does the holding period matter?3 mo: +2.3 pts 49% beat6 mo: +4.6 pts 49% beat12 mo: +12.6 pts 50% beat24 mo: +21.8 pts 46% beat3 yr, per yr: +1.3 pts 40% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today1,245+7.9 pts t 4.6+10.1 pts
Sell-off (S&P ≥10% off high)182+44.5 pts t 4.0+40.7 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing466+13.0 pts t 4.0−2.2 pts
Energy126+7.4 pts t 1.2−7.8 pts
Other115+8.4 pts t 1.8+3.8 pts
Tech hardware & semis113+10.9 pts t 1.6+2.3 pts
Services96+11.9 pts t 2.7+12.2 pts
Retail & consumer87+17.2 pts t 2.1+10.2 pts
Finance & real estate72−1.7 pts t -0.5−2.4 pts
Utilities65+5.6 pts t 0.6−1.2 pts
Construction53+13.2 pts t 1.7−2.4 pts
Biotech & pharma44+47.1 pts t 1.6+10.0 pts
Telecom & media43+14.0 pts t 0.7−6.3 pts
Software & IT services35+39.9 pts t 1.8+1.2 pts

Holds up out of sample? Before 2018: +10.7 pts (n 629, t 6.0). From 2018: +14.0 pts (n 798, t 4.1). Same sign in both halves.

Year2010201120122013201420152016201720182019202020212022202320242025
vs S&P+13 pts+5 pts+14 pts+18 pts−4 pts−4 pts+22 pts+12 pts−3 pts−15 pts+87 pts+8 pts+17 pts−9 pts−7 pts+15 pts
n254310610178841118178991297276108121115

Read the research behind this screen: Price-to-book still sorts, across all sizes → · Test your own combination in the Screen Lab →

Our model values are recomputed daily but were never stored historically, so this band cannot be backtested honestly yet. Daily snapshots began 2026-09-10; a true record accrues from there. Until then the nearest tested cousin is shown — cheap on book value — and labelled as a proxy. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

INNV
InnovAge Holding Corp.
Deeply overvalued
Healthcare Risk 60 · High
Price$10.75
Model IV$2.09
P/IV3.63
Premium +414% Return to IV: -80.5%
Market implies +28.8%/yr vs model +8.3% · above model
INOD
INNODATA INC
Deeply overvalued
Technology Risk 58 · Elevated
Price$53.21
Model IV$30.22
P/IV3.47
Premium +76% Return to IV: -43.2%
Market implies +15.7%/yr vs model +37.8% · below model
INSE
Inspired Entertainment, Inc.
Overvalued
Technology Risk 73 · High
Price$5.10
Model IV$4.32
P/IV1.78
Premium +18% Return to IV: -15.3%
Market implies +8.8%/yr vs model +10.8% · in line
INSG
INSEEGO CORP.
Deeply overvalued
Technology Risk 60 · High
Price$4.47
Model IV$7.80
P/IV1.68
Discount 43% Return to IV: +74.6%
Market implies -5.6%/yr vs model +2.0% · below model
INSM
INSMED Inc
Deeply overvalued
Healthcare Risk 63 · High
Price$119.92
Model IV$23.52
P/IV4.55
Premium +410% Return to IV: -80.4%
Market implies +13.6%/yr vs model +33.9% · below model
INTA
Intapp, Inc.
Deeply overvalued
Technology Risk 53 · Elevated
Price$37.49
Model IV$15.02
P/IV1.54
Premium +150% Return to IV: -59.9%
Market implies +27.0%/yr vs model +20.3% · above model
INTG
INTERGROUP CORP
Deeply overvalued
Real Estate Risk 68 · High
Price$37.74
Model IV$20.31
P/IV1.91
Premium +86% Return to IV: -46.2%
INTJ
Intelligent Group Ltd
Deeply overvalued
Industrials Risk 61 · High
Price$3.00
Model IV$3.51
P/IV2.71
Discount 15% Return to IV: +17.0%
Market implies -13.4%/yr vs model +15.0% · below model
INTT
INTEST CORP
Deeply overvalued
Healthcare Risk 70 · High
Price$11.42
Model IV$4.63
P/IV3.64
Premium +147% Return to IV: -59.4%
Market implies +17.1%/yr vs model +8.3% · above model
INVE
Identiv, Inc.
Deeply overvalued
Technology Risk 53 · Elevated
Price$2.58
Model IV$0.87
P/IV4.73
Premium +198% Return to IV: -66.4%
Market implies +10.8%/yr vs model +2.0% · above model
IOR
INCOME OPPORTUNITY REALTY INVESTORS INC /TX/
Deeply overvalued
Financial Services Risk 58 · Elevated
Price$18.50
Model IV$8.94
P/IV2.01
Premium +107% Return to IV: -51.7%
IOT
Samsara Inc.
Deeply overvalued
Technology Risk 53 · Elevated
Price$41.65
Model IV$19.32
P/IV1.81
Premium +116% Return to IV: -53.6%
Market implies +10.8%/yr vs model +39.4% · below model
IOTR
iOThree Ltd
Undervalued
Communication Services Risk 68 · High
Price$2.02
Model IV$2.57
P/IV1.52
Discount 21% Return to IV: +27.1%
Market implies -2.5%/yr vs model +50.0% · below model
IP
INTERNATIONAL PAPER CO /NEW/
Deeply overvalued
Basic Materials Risk 57 · Elevated
Price$33.99
Model IV$25.01
P/IV1.34
Premium +36% Return to IV: -26.4%
Market implies +8.5%/yr vs model +5.1% · above model
IPGP
IPG PHOTONICS CORP
Deeply overvalued
Technology Risk 63 · High
Price$79.99
Model IV$24.94
P/IV4.59
Premium +221% Return to IV: -68.8%
Market implies +19.8%/yr vs model +2.0% · above model
IPSC
Century Therapeutics, Inc.
Deeply overvalued
Healthcare Risk 56 · Elevated
Price$1.94
Model IV$0.57
P/IV4.32
Premium +242% Return to IV: -70.8%
Market implies +22.7%/yr vs model +15.0% · above model
IPW
iPower Inc.
Deeply overvalued
Consumer Cyclical Risk 65 · High
Price$1.77
Model IV$0.96
P/IV4.01
Premium +84% Return to IV: -45.8%
Market implies +8.9%/yr vs model +5.2% · above model
IR
Ingersoll Rand Inc.
Deeply overvalued
Industrials Risk 48 · Elevated
Price$72.93
Model IV$49.92
P/IV1.44
Premium +46% Return to IV: -31.6%
Market implies +13.9%/yr vs model +10.3% · above model
IRD
Opus Genetics, Inc.
Deeply overvalued
Healthcare Risk 60 · High
Price$6.04
Model IV$1.60
P/IV2.73
Premium +278% Return to IV: -73.5%
Market implies +16.1%/yr vs model +50.0% · below model
IRM
IRON MOUNTAIN INC
Deeply overvalued
Financial Services Risk 68 · High
Price$115.18
Model IV$47.42
P/IV2.70
Premium +143% Return to IV: -58.8%
IRMD
IRADIMED CORP
Deeply overvalued
Healthcare Risk 52 · Elevated
Price$82.53
Model IV$37.26
P/IV2.43
Premium +122% Return to IV: -54.9%
Market implies +22.0%/yr vs model +16.3% · above model
ISBA
ISABELLA BANK CORP
Deeply overvalued
Financial Services Risk 69 · High
Price$39.36
Model IV$27.62
P/IV1.48
Premium +43% Return to IV: -29.8%
ISRG
INTUITIVE SURGICAL INC
Deeply overvalued
Healthcare Risk 58 · Elevated
Price$377.94
Model IV$135.74
P/IV3.13
Premium +178% Return to IV: -64.1%
Market implies +24.3%/yr vs model +13.7% · above model
ISSC
INNOVATIVE SOLUTIONS & SUPPORT INC
Deeply overvalued
Technology Risk 60 · High
Price$20.95
Model IV$5.28
P/IV3.26
Premium +297% Return to IV: -74.8%
Market implies +39.7%/yr vs model +25.0% · above model
ITGR
Integer Holdings Corp
Deeply overvalued
Healthcare Risk 49 · Elevated
Price$126.00
Model IV$66.32
P/IV1.35
Premium +90% Return to IV: -47.4%
Market implies +16.8%/yr vs model +10.7% · above model
ITT
ITT INC.
Deeply overvalued
Industrials Risk 55 · Elevated
Price$204.14
Model IV$120.76
P/IV1.61
Premium +69% Return to IV: -40.8%
Market implies +15.5%/yr vs model +10.2% · above model
ITW
ILLINOIS TOOL WORKS INC
Deeply overvalued
Industrials Risk 55 · Elevated
Price$268.16
Model IV$189.02
P/IV1.31
Premium +42% Return to IV: -29.5%
Market implies +9.3%/yr vs model +5.6% · above model
IVR
Invesco Mortgage Capital Inc.
Valuation N/A
Financial Services Risk 45 · Elevated
Price$6.80
Model IV
P/IV
Limited data — see page
IVT
InvenTrust Properties Corp.
Overvalued
Financial Services Risk 67 · High
Price$31.73
Model IV$24.82
P/IV1.33
Premium +28% Return to IV: -21.8%
IZEA
IZEA Worldwide, Inc.
Deeply overvalued
Technology Risk 53 · Elevated
Price$2.89
Model IV$0.83
P/IV4.43
Premium +247% Return to IV: -71.2%
Market implies +17.7%/yr vs model +4.3% · above model
J
JACOBS SOLUTIONS INC.
Deeply overvalued
Industrials Risk 55 · Elevated
Price$141.85
Model IV$46.73
P/IV2.56
Premium +204% Return to IV: -67.1%
Market implies +16.5%/yr vs model +0.9% · above model
JBGS
JBG SMITH Properties
Deeply overvalued
Financial Services Risk 73 · High
Price$11.37
Model IV$8.32
P/IV1.76
Premium +37% Return to IV: -26.8%
JBHT
HUNT J B TRANSPORT SERVICES INC
Deeply overvalued
Industrials Risk 58 · Elevated
Price$270.45
Model IV$151.18
P/IV1.83
Premium +79% Return to IV: -44.1%
Market implies +12.2%/yr vs model +5.2% · above model
JBL
JABIL INC
Deeply overvalued
Technology Risk 54 · Elevated
Price$298.72
Model IV$115.16
P/IV3.17
Premium +159% Return to IV: -61.4%
Market implies +20.7%/yr vs model +7.9% · above model
JCI
Johnson Controls International plc
Deeply overvalued
Industrials Risk 55 · Elevated
Price$146.01
Model IV$50.10
P/IV2.68
Premium +191% Return to IV: -65.7%
Market implies +19.0%/yr vs model +5.4% · above model
JEM
707 Cayman Holdings Ltd.
Valuation N/A
Consumer Cyclical Risk 50 · Elevated
Price$4.01
Model IV
P/IV
Market implies +19.8%/yr vs model +15.0% · above model
JFB
JFB Construction Holdings
Deeply overvalued
Industrials Risk 57 · Elevated
Price$4.95
Model IV$1.26
P/IV4.59
Premium +293% Return to IV: -74.6%
Market implies +21.3%/yr vs model +32.3% · below model
JFU
9F Inc.
Deeply overvalued
Financial Services Risk 58 · Elevated
Price$2.70
Model IV$1.99
P/IV1.54
Premium +36% Return to IV: -26.3%
Market implies +9.8%/yr vs model +8.0% · in line
JLHL
Julong Holding Ltd
Overvalued
Industrials Risk 55 · Elevated
Price$6.09
Model IV$4.89
P/IV4.00
Premium +24% Return to IV: -19.7%
Market implies -5.7%/yr vs model +15.0% · below model
JMG
JM Group Ltd
Deeply overvalued
Industrials Risk 56 · Elevated
Price$6.61
Model IV$2.94
P/IV2.25
Premium +125% Return to IV: -55.5%
Market implies +13.1%/yr vs model +6.0% · above model
JOUT
JOHNSON OUTDOORS INC
Deeply overvalued
Consumer Cyclical Risk 55 · Elevated
Price$44.61
Model IV$32.36
P/IV1.38
Premium +38% Return to IV: -27.5%
Market implies +0.1%/yr vs model -1.6% · in line
JYNT
JOINT Corp
Deeply overvalued
Financial Services Risk 58 · Elevated
Price$8.30
Model IV$3.08
P/IV2.89
Premium +170% Return to IV: -62.9%
KAI
KADANT INC
Deeply overvalued
Industrials Risk 58 · Elevated
Price$266.30
Model IV$150.75
P/IV2.12
Premium +77% Return to IV: -43.4%
Market implies +12.8%/yr vs model +5.4% · above model
KD
Kyndryl Holdings, Inc.
Deeply overvalued
Technology Risk 60 · High
Price$13.15
Model IV$8.50
P/IV1.47
Premium +55% Return to IV: -35.4%
Market implies +4.0%/yr vs model -0.7% · above model
KE
Kimball Electronics, Inc.
Deeply overvalued
Technology Risk 59 · Elevated
Price$26.17
Model IV$7.73
P/IV3.36
Premium +239% Return to IV: -70.5%
Market implies +22.0%/yr vs model +6.1% · above model
KEN
Kenon Holdings Ltd.
Deeply overvalued
Utilities Risk 57 · Elevated
Price$65.89
Model IV$42.31
P/IV2.15
Premium +56% Return to IV: -35.8%
KEP
KOREA ELECTRIC POWER CORP
Deeply overvalued
Utilities Risk 60 · High
Price$12.21
Model IV$5.59
P/IV2.35
Premium +118% Return to IV: -54.2%
KEYS
Keysight Technologies, Inc.
Deeply overvalued
Healthcare Risk 65 · High
Price$313.36
Model IV$84.02
P/IV4.03
Premium +273% Return to IV: -73.2%
Market implies +24.4%/yr vs model +6.4% · above model
KFFB
Kentucky First Federal Bancorp
Deeply overvalued
Financial Services Risk 61 · High
Price$5.66
Model IV$2.91
P/IV1.64
Premium +95% Return to IV: -48.6%
KGS
Kodiak Gas Services, Inc.
Overvalued
Utilities Risk 57 · Elevated
Price$56.62
Model IV$47.58
P/IV1.41
Premium +19% Return to IV: -16.0%
KINS
KINGSTONE COMPANIES, INC.
Deeply overvalued
Financial Services Risk 60 · High
Price$19.22
Model IV$4.62
P/IV3.22
Premium +316% Return to IV: -76.0%
KKR
KKR & Co. Inc.
Deeply overvalued
Financial Services Risk 58 · Elevated
Price$101.08
Model IV$19.82
P/IV4.84
Premium +410% Return to IV: -80.4%
Market implies +24.9%/yr vs model +4.7% · above model
KMI
KINDER MORGAN, INC.
Deeply overvalued
Utilities Risk 63 · High
Price$30.96
Model IV$22.31
P/IV1.39
Premium +39% Return to IV: -27.9%
KMRK
K-TECH SOLUTIONS CO LTD
Undervalued
Consumer Cyclical Risk 53 · Elevated
Price$0.97
Model IV$1.22
P/IV1.80
Discount 21% Return to IV: +26.0%
Market implies -14.1%/yr vs model +5.8% · below model
KMT
KENNAMETAL INC
Deeply overvalued
Industrials Risk 67 · High
Price$29.42
Model IV$17.01
P/IV1.93
Premium +73% Return to IV: -42.2%
Market implies +11.9%/yr vs model +5.0% · above model
KMTS
KESTRA MEDICAL TECHNOLOGIES, LTD.
Deeply overvalued
Healthcare Risk 57 · Elevated
Price$22.85
Model IV$9.40
P/IV2.26
Premium +143% Return to IV: -58.9%
Market implies +15.8%/yr vs model +50.0% · below model
KMX
CARMAX INC
Deeply overvalued
Consumer Cyclical Risk 68 · High
Price$61.32
Model IV$22.70
P/IV1.97
Premium +170% Return to IV: -63.0%
Market implies +15.9%/yr vs model +1.6% · above model
KNDI
Kandi Technologies Group, Inc.
Deeply overvalued
Consumer Cyclical Risk 55 · Elevated
Price$0.61
Model IV$0.48
P/IV1.74
Premium +27% Return to IV: -21.5%
Market implies -0.4%/yr vs model +0.0% · in line
KNF
Knife River Corp
Deeply overvalued
Basic Materials Risk 68 · High
Price$57.63
Model IV$27.52
P/IV2.85
Premium +109% Return to IV: -52.2%
Market implies +16.9%/yr vs model +7.8% · above model
KNSL
Kinsale Capital Group, Inc.
Deeply overvalued
Financial Services Risk 66 · High
Price$369.20
Model IV$202.57
P/IV1.50
Premium +82% Return to IV: -45.1%